At a glance
Executive Summary
CRM pipeline + real P&L financials · Surgery_Date is source of truth for monthly counts
Total cases (P&L)
908
Aug '25 – Mar '26
Total billings
₹8.90 Cr
Avg ₹1.02L/case
MediEND share
₹3.63 Cr
50.6% avg share
Net profit (P&L)
₹2.67 Cr
Avg ₹29.4K/case
Avg monthly cases
~130
P&L period (excl Aug)
CRM conv rate
1.90%
110K leads processed
Revenue growing: Monthly billings rose from ₹75L (Sep '25) to ₹1.66Cr (Jan '26). Dec '25 and Jan '26 were peak months at ₹1.66Cr each. Average profit per case improved from ₹19.7K → ₹37K as case mix shifted to higher-value treatments.
Payment mix: 74% Cashless, 20% Cash, 5% EMI. Cashless dominance means revenue depends on insurance approvals — a key operational risk that should be tracked separately.
Mumbai leads in profit: ₹1.10Cr net profit (41% of total) on 308 cases. New Delhi has 303 cases but only ₹80.8L profit — margin gap of ₹9,200/case vs Mumbai that needs investigation.
Rhinoplasty highest margin: Avg ₹65,959 profit/case. Sleeve Gastrectomy at ₹1.15L/case. Only 24 and 8 cases respectively — large upside if volume scales.
Monthly net profit trend
MediEND net profit · Aug '25 – Mar '26
Billings vs net profit by circle
Top 4 circles · ₹ Cr
Payment mix
908 cases · Aug '25 – Mar '26
Team performance — CRM conversions ranked
| Team Lead | BDs | Leads | IPD Done | Conv % | Junk % | Rating |
|---|
Financial intelligence
P&L Analysis
Real financials from IPD P&L master sheet · Aug 2025 – Mar 2026 · 908 cases
Total bill amount
₹8.90 Cr
Avg ₹1,01,896/case
MediEND net profit
₹2.67 Cr
Avg ₹29,387/case
↑ Growing MoM
MediEND avg share
50.6%
Hospital gets 49.4%
Run rate (Mar '26)
₹4.15L
Monthly net profit
Monthly billings vs net profit
₹ in lakhs
Avg profit per case by month
₹ per surgery
Net profit by treatment
Total ₹ · top 10
Avg profit per case by treatment
₹/surgery · quality metric
Treatment P&L breakdown
Click headers to sort
| Treatment | Cases | Total Billing | Net Profit | Avg Bill | Avg Profit | MediEND % | Margin |
|---|
Top 10 doctors by cases & revenue
P&L period · click to sort
| Doctor | Cases | Total Billing | Net Profit | Avg Bill/Case |
|---|
Best margin treatment: Rhinoplasty averages ₹65,959 profit/case on ₹2.15L avg billing. Sleeve Gastrectomy averages ₹1.15L/case but only 8 cases. Scaling these high-ticket procedures could dramatically improve revenue without needing more cases.
Circumcision volume risk: 256 cases (28% of volume) at only ₹14,663 avg profit/case. Lowest margin in the portfolio. Business is subsidised by Lipoma and Gynecomastia — any dip in these two will significantly hurt profitability.
Pipeline
Conversion Funnel
Where 110,176 leads end up across 15 months
Leads in
110K
IPD Done
2,096
1.90% of total
Active pipeline
~3,500
Workable leads
DNP Exhausted
15,054
Re-engage pool
Wasted
75K+
68% lost
Full status distribution
Junk breakdown
DNP Exhausted (15,054) is a recoverable pool. Structured WA re-engagement could convert 2–3% = 300–450 additional IPDs at near-zero cost.
Non-junk conversion: Removing junk/dup/invalid, real conversion rate jumps to 2.98%.
Individual performance
BD Scorecards
CRM conversion performance · click any header to sort
Tier 1 — Star (Conv ≥ 5%)
Tier 2 — Above average (2–5%)
Tier 3 — Below average (0.5–2%)
Tier 4 — Critical (< 0.5% or zero)
Team intelligence
Team Analysis
Performance by team lead · click headers to sort
Active teams
8
Best conv
2.69%
Amit Shukla
Worst conv
0.42%
Abhishek Kashyap
Avg junk rate
36%
Team conversion rates
Team junk rates
Team detail table
Click headers to sort
| Team Lead | BDs | Leads | IPD Done | OPD | Junk | Junk % | Conv % | Rating |
|---|
Financial people view
BD Revenue Performance
P&L data Aug '25 – Mar '26 · actual billings and profit per BD
Top BD by cases
Ayan Siddiqui
68 cases · ₹1.69L profit
Highest avg profit/case
Sumit Pal
₹50,169/case · 39 cases
Most revenue generated
Ayan Siddiqui
₹80.6L total billing
Avg billing/case (all)
₹1.02L
Across 908 cases
Cases per BD (top 15)
Avg profit per case by BD
Quality of business generated
BD P&L table
Click headers to sort · P&L period only
| BD Name | Cases | Total Billing | Net Profit | Avg Bill/Case | Avg Profit/Case | Efficiency |
|---|
Channel intelligence
Source Quality
ROI by acquisition channel · CRM conversion rates
Best conv source
67.6%
Referral · 34 leads
Highest volume
Facebook
66,372 leads · 2.53%
Worst ROI
ProData
12,357 leads · 0.17%
Hidden gem
Inbound
9.0% conv · low junk
Conversion rate by source
Volume vs. conversion
Bubble = lead volume
Source ROI table
Click to sort
| Source | Leads | IPD Done | Junk | Junk % | Conv % | Assessment | Action |
|---|
Clinical + financial mix
Disease Mix
Treatment breakdown with real P&L financials · CRM volume + surgery profitability
Highest volume
Lipoma
38K leads · ₹9.38L profit
Highest margin/case
Rhinoplasty
₹65,959 avg profit
Best CRM conv
Gynecomastia
2.95% conv rate
Worst conv
Proctology
10K leads · 0.27%
Category volume share
Category conversion rates
Treatment: CRM + P&L combined
Click to sort
| Treatment | Category | CRM Leads | CRM Conv % | P&L Cases | Avg Bill | Avg Profit | MediEND % | Priority |
|---|
Geographic intelligence
Circle Analysis
City-level performance · CRM conversion + real P&L profitability
Highest CRM conv
Pune 2.48%
20,290 leads
Highest P&L profit
Mumbai
₹1.10Cr · ₹35.9K/case
Best avg profit/case
Mumbai
₹35,867/case
Underperforming
Bangalore
7K leads · 0.84% conv
CRM leads vs IPD done by circle
P&L net profit by circle
Total ₹ · Aug '25 – Mar '26
Circle combined table · CRM + P&L
Click to sort
| Circle | CRM Leads | CRM IPD | CRM Conv % | P&L Cases | Total Billing | Net Profit | Avg Profit/Case | Priority |
|---|
Time series
Monthly Trends
Real surgery counts (Surgery_Date) · CRM lead volume · P&L financials
Peak surgeries
Jun '25 · 120
Peak billing month
Jan '26 · ₹1.66Cr
Current run rate
~130/mo
P&L period avg
Best profit month
Dec '25 · ₹49.3L
Monthly surgeries · Surgery_Date (CRM) vs P&L cases
Target line at 200
Monthly billing & net profit (P&L)
₹ in lakhs
CRM lead volume by month
Full monthly data table
Click to sort
| Month | CRM Leads | Surgeries (Surgery_Date) | P&L Cases | Total Billing | Net Profit | Avg Profit/Case |
|---|
Strategic roadmap
200 IPD/Month Target
P&L-backed: at ₹29.4K avg profit/case, 200/month = ₹58.8L/month net profit
Monthly target
200
surgeries/month · ₹58.8L net profit at current avg
Current (P&L avg)
~130
Sep '25–Mar '26
Gap
+70/mo
From P&L baseline
Revenue at target
₹58.8L
Monthly net profit
Where the +70 cases come from
Scale Referral programme+15–25
Redeploy zero-output BD leads+12–20
Google Ads + Inbound scale-up+10–18
BD training (Tier 3→2 uplift)+8–15
DNP Exhausted re-engagement+8–12
Total potential uplift+53–90/month
6-month action plan
1
Scale Referral programme (Month 1)
At 67.6% conversion, 150 referral leads = ~100 cases. P&L shows avg ₹29.4K profit. A ₹2,000/patient referral incentive costs ₹3L for 150 referrals but generates ₹30L profit. ROI: 10×. Build a WhatsApp-based patient referral system with tracking codes.
+15–25 cases · immediate2
Redeploy zero-output BD leads (Month 1)
Sanjana Sharma (8,067 leads, 0 IPD), Rajesh Kumar (3,843, 0), Avinash Singh (1,509, 0). Reassigning their incoming leads to top BDs like Mayank Panday (5.21%) could yield +12–20 cases/month at existing lead volumes.
+12–20 cases · month 13
Shift budget: ProData → Google Ads (Month 1–2)
ProData: 12,357 leads, 0.17% conv. Google: 3.90% conv, 54% better than Facebook. Shifting ₹5L/month from ProData to Google Ads (est. 500–800 additional leads) generates 20–31 extra cases vs. 2 cases from ProData for same spend.
+10–18 cases · month 24
BD training: replicate top performers (Month 2–3)
Mayank Panday (5.21%), Kapil Sharma (3.68%), Sumit Pal (₹50K avg profit/case) are the playbook. P&L data shows top BDs generate 30–70% higher avg billing than bottom tier — not just more cases but better cases. Run structured call shadowing and monthly case reviews.
+8–15 cases · growing5
DNP re-engagement campaign (Month 2–3)
15,054 DNP Exhausted leads. Fund Issues (2,344) and Out of Station (3,480) are most likely to convert with right offer. EMI payment option (currently only 4.5% of P&L cases) is underutilised — promote EMI in re-engagement messaging to remove price barrier.
+8–12 cases · month 36
Focus on high-margin treatments (Month 3–6)
Rhinoplasty (₹65,959/case), Sleeve Gastrectomy (₹1.15L/case), Auxillary Breast (₹38,873/case) are severely underrepresented in the pipeline. Dedicated campaigns for these treatments — even 10 extra Rhinoplasty cases/month = ₹6.6L additional net profit vs. 10 Circumcision cases at ₹1.47L.
Revenue uplift · month 4+Projected trajectory to 200 cases/month + revenue impact